BioCentury
ARTICLE | Clinical News

Dry powder inhalation technology regulatory update

October 23, 2000 7:00 AM UTC

DURA received U.S. Patent No. 6,116,237 covering its dry powder inhalation technology for use in systemic and topical drug delivery. DURA is being acquired by Elan Corp. plc (ELN, Dublin, Ireland) (s...

Get Unlimited Access
Continue reading with a free trial.
Or Purchase This Article